PapersPMID:26854844
Purslane Extract and Glucose Homeostasis in Adults with Type 2 Diabetes: A Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety.
What moved
1 findingHow to read these marks →- Decreases systolic blood pressure
very limited
“In the total cohort, systolic blood pressure declined significantly more in the PE group than the placebo group: -7.5 ± 5.0 versus -0.01 ± 0.3 mmHg, P < .0001.”
- Study
- RCT
- Duration
- 3 months
- Dose studied
- three capsules of purslane extract per day for 12 weeks
- Population
- adults with type 2 diabetes treated with a single oral hypoglycemic agent at baseline in both arms
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Adults with type 2 diabetes mellitus on a single oral hypoglycemic agent at baseline; purslane extract (PE) capsules vs matched placebo; abstract only
- Participants
- 63
- Comparator
- placebo
- Duration
- 84 days
- Endpoints measured
- 2